UB Paderborn / Katalog / Suche / in CDI

Production of complement components by cells of the immune system

Clinical and experimental immunology, 2017-05, Vol.188 (2), p.183-194

2017

Link zum Volltext

Verfügbarkeit prüfen

Complement activation and inhibition: a delicate balance

Trends in immunology, 2009-02, Vol.30 (2), p.83-90

2009

Link zum Volltext

Verfügbarkeit prüfen

Biomarkers for rheumatoid and psoriatic arthritis

Clinical immunology (Orlando, Fla.), 2015-11, Vol.161 (1), p.2-10

2015

Link zum Volltext

Verfügbarkeit prüfen

Anti‐C1q autoantibodies may not serve as an adequate biomarker for lung manifestations in systemic sclerosis: a single‐centre, cross‐sectional study

British journal of dermatology (1951), 2021-09, Vol.185 (3), p.657-658

2021

Link zum Volltext

Verfügbarkeit prüfen

Role of complement and complement regulators in the removal of apoptotic cells

Molecular immunology, 2008-03, Vol.45 (5), p.1199-1207

2008

Link zum Volltext

Verfügbarkeit prüfen

Anticitrullinated protein antibodies and rheumatoid factor are associated with increased mortality but with different causes of death in patients with rheumatoid arthritis: a longitudinal study in three European cohorts

Annals of the rheumatic diseases, 2016-11, Vol.75 (11), p.1924-1932

2016

Link zum Volltext

Verfügbarkeit prüfen

Anti-carbamylated protein antibodies: a specific hallmark for rheumatoid arthritis. Comparison to conditions known for enhanced carbamylation; renal failure, smoking and chronic inflammation

Annals of the rheumatic diseases, 2016-08, Vol.75 (8), p.1575-1576

2016

Link zum Volltext

Verfügbarkeit prüfen

The association between anti-carbamylated protein (anti-CarP) antibodies and radiographic progression in early rheumatoid arthritis: a study exploring replication and the added value to ACPA and rheumatoid factor

Annals of the rheumatic diseases, 2017-01, Vol.76 (1), p.112

2017

Link zum Volltext

Verfügbarkeit prüfen

Added value of multiple autoantibody testing for predicting progression to inflammatory arthritis in at-risk individuals

Rheumatic & musculoskeletal diseases open, 2022-12, Vol.8 (2), p.e002512

2022

Link zum Volltext

Verfügbarkeit prüfen

Autoantibodies are major predictors of arthritis development in patients with anti-citrullinated protein antibodies and musculoskeletal pain

Scandinavian journal of rheumatology, 2021-05, Vol.50 (3), p.189-197

2021

Link zum Volltext

Verfügbarkeit prüfen

Rheumatoid arthritis phenotype at presentation differs depending on the number of autoantibodies present

Annals of the rheumatic diseases, 2017-04, Vol.76 (4), p.716

2017

Link zum Volltext

Verfügbarkeit prüfen

Anti-citrullinated protein antibodies have a low avidity compared with antibodies against recall antigens

Annals of the rheumatic diseases, 2011-02, Vol.70 (2), p.373-379

2011

Link zum Volltext

Verfügbarkeit prüfen

Type 17-specific immune pathways are active in early spondyloarthritis

Rheumatic & musculoskeletal diseases open, 2023-12, Vol.9 (4), p.e003328

2023

Link zum Volltext

Verfügbarkeit prüfen

New biomarkers in rheumatoid arthritis

Netherlands journal of medicine, 2012-11, Vol.70 (9), p.392-399

2012

Link zum Volltext

Verfügbarkeit prüfen

Novel genetic association of the VTCN1 region with rheumatoid arthritis

Annals of the rheumatic diseases, 2012-04, Vol.71 (4), p.567-571

2012

Link zum Volltext

Verfügbarkeit prüfen

Genetic variants in the region of the C1q genes are associated with rheumatoid arthritis

Clinical and experimental immunology, 2013-07, Vol.173 (1), p.76-83

2013

Link zum Volltext

Verfügbarkeit prüfen

Presence of anticitrullinated protein antibodies in a large population-based cohort from the Netherlands

Annals of the rheumatic diseases, 2017-07, Vol.76 (7), p.1184

2017

Link zum Volltext

Verfügbarkeit prüfen

C-reactive protein in myocardial infarction binds to circulating microparticles but is not associated with complement activation

Clinical immunology (Orlando, Fla.), 2010-06, Vol.135 (3), p.490-495

2010

Link zum Volltext

Verfügbarkeit prüfen

Auto-antibodies to post-translationally modified proteins in osteoarthritis

Osteoarthritis and cartilage, 2021-06, Vol.29 (6), p.924-933

2021

Link zum Volltext

Verfügbarkeit prüfen

The major risk alleles of age‐related macular degeneration (AMD) in CFH do not play a major role in rheumatoid arthritis (RA)

Clinical and experimental immunology, 2011-12, Vol.166 (3), p.333-337

2011

Link zum Volltext

Verfügbarkeit prüfen

Diagnostic and prognostic significance of anti-C1q antibodies in systemic lupus erythematosus

Current opinion in nephrology and hypertension, 2003-11, Vol.12 (6), p.619-624

2003

Link zum Volltext

Verfügbarkeit prüfen

Complement activation in Glioblastoma Multiforme pathophysiology: Evidence from serum levels and presence of complement activation products in tumor tissue

Journal of neuroimmunology, 2015-01, Vol.278, p.271-276

2015

Link zum Volltext

Verfügbarkeit prüfen

Glomerular deposition of C1q and anti‐C1q antibodies in mice following injection of antimouse C1q antibodies

Clinical and experimental immunology, 2003-04, Vol.132 (1), p.32-39

2003

Link zum Volltext

Verfügbarkeit prüfen

Complement component C1q is produced by isolated articular chondrocytes

Osteoarthritis and cartilage, 2020-05, Vol.28 (5), p.675-684

2020

Link zum Volltext

Verfügbarkeit prüfen

Menü

Weitere Dienste

Einstellungen

Production of complement components by cells of the immune system

Complement activation and inhibition: a delicate balance

Biomarkers for rheumatoid and psoriatic arthritis

Anti‐C1q autoantibodies may not serve as an adequate biomarker for lung manifestations in systemic sclerosis: a single‐centre, cross‐sectional study

Role of complement and complement regulators in the removal of apoptotic cells

Anticitrullinated protein antibodies and rheumatoid factor are associated with increased mortality but with different causes of death in patients with rheumatoid arthritis: a longitudinal study in three European cohorts

Anti-carbamylated protein antibodies: a specific hallmark for rheumatoid arthritis. Comparison to conditions known for enhanced carbamylation; renal failure, smoking and chronic inflammation

The association between anti-carbamylated protein (anti-CarP) antibodies and radiographic progression in early rheumatoid arthritis: a study exploring replication and the added value to ACPA and rheumatoid factor

Added value of multiple autoantibody testing for predicting progression to inflammatory arthritis in at-risk individuals

Autoantibodies are major predictors of arthritis development in patients with anti-citrullinated protein antibodies and musculoskeletal pain

Rheumatoid arthritis phenotype at presentation differs depending on the number of autoantibodies present

Anti-citrullinated protein antibodies have a low avidity compared with antibodies against recall antigens

Type 17-specific immune pathways are active in early spondyloarthritis

New biomarkers in rheumatoid arthritis

Novel genetic association of the VTCN1 region with rheumatoid arthritis

Genetic variants in the region of the C1q genes are associated with rheumatoid arthritis

Presence of anticitrullinated protein antibodies in a large population-based cohort from the Netherlands

Prolonged activation of nasal immune cell populations and development of tissue-resident SARS-CoV-2-specific CD8 + T cell responses following COVID-19

C-reactive protein in myocardial infarction binds to circulating microparticles but is not associated with complement activation

Auto-antibodies to post-translationally modified proteins in osteoarthritis

The major risk alleles of age‐related macular degeneration (AMD) in CFH do not play a major role in rheumatoid arthritis (RA)

Diagnostic and prognostic significance of anti-C1q antibodies in systemic lupus erythematosus

Complement activation in Glioblastoma Multiforme pathophysiology: Evidence from serum levels and presence of complement activation products in tumor tissue

Glomerular deposition of C1q and anti‐C1q antibodies in mice following injection of antimouse C1q antibodies

Complement component C1q is produced by isolated articular chondrocytes

Suchergebnisse filtern